To the Editor Dr Joffe1 argued for the importance of randomized study designs to ensure the acquisition of scientific knowledge required for the response to the Ebola epidemic to progress, as well as to ensure ethical treatment of patients. Many calls for RCTs have culminated with the establishment, by the Wellcome Trust, of an international consortium to conduct clinical trials of experimental therapeutics for Ebola virus disease in West Africa.2
Kanters S, Thorlund K, Mills EJ. Ethical Testing of Experimental Ebola Treatments. JAMA. 2015;313(4):421–422. doi:10.1001/jama.2014.17259
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: